• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Relationship Between COVID-19 Cases and COVID-19 Testing: a Panel Data Analysis on OECD Countries.新冠病毒疾病病例与新冠病毒检测之间的关系:经合组织国家的面板数据分析
J Knowl Econ. 2022;13(3):1737-1750. doi: 10.1007/s13132-021-00792-z. Epub 2021 Apr 13.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
The asymmetric nexus between air pollution and COVID-19: Evidence from a non-linear panel autoregressive distributed lag model.空气污染与 COVID-19 之间的非对称关系:来自非线性面板自回归分布滞后模型的证据。
Environ Res. 2022 Jun;209:112848. doi: 10.1016/j.envres.2022.112848. Epub 2022 Jan 29.
4
Phase and wave dependent analysis of health expenditure efficiency: A sample of OECD evidence.基于相位和波的健康支出效率分析:OECD 证据样本。
Front Public Health. 2023 Mar 17;11:1125975. doi: 10.3389/fpubh.2023.1125975. eCollection 2023.
5
Analyzing the impact of fiscal conditions on private health expenditures in OECD countries: a quantile ARDL investigation.分析财政状况对经合组织国家私人卫生支出的影响:分位数 ARDL 研究。
Int J Health Econ Manag. 2024 Sep;24(3):439-463. doi: 10.1007/s10754-024-09377-0. Epub 2024 May 22.
6
Does military spending stifle economic growth? The empirical evidence from non-OECD countries.军事开支会抑制经济增长吗?来自非经合组织国家的实证证据。
Heliyon. 2020 Dec 28;6(12):e05853. doi: 10.1016/j.heliyon.2020.e05853. eCollection 2020 Dec.
7
Travel-related control measures to contain the COVID-19 pandemic: a rapid review.旅行相关的控制措施以遏制 COVID-19 大流行:快速综述。
Cochrane Database Syst Rev. 2020 Oct 5;10:CD013717. doi: 10.1002/14651858.CD013717.
8
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
9
International travel-related control measures to contain the COVID-19 pandemic: a rapid review.国际旅行相关防控措施以遏制 COVID-19 大流行:快速综述。
Cochrane Database Syst Rev. 2021 Mar 25;3(3):CD013717. doi: 10.1002/14651858.CD013717.pub2.
10
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.

本文引用的文献

1
Modelling the impact of testing, contact tracing and household quarantine on second waves of COVID-19.建模测试、接触者追踪和家庭隔离对 COVID-19 第二波疫情的影响。
Nat Hum Behav. 2020 Sep;4(9):964-971. doi: 10.1038/s41562-020-0931-9. Epub 2020 Aug 5.
2
Serology testing in the COVID-19 pandemic response.新冠疫情应对中的血清学检测。
Lancet Infect Dis. 2020 Sep;20(9):e245-e249. doi: 10.1016/S1473-3099(20)30517-X. Epub 2020 Jul 17.
3
COVID-19 diagnostic approaches: different roads to the same destination.COVID-19诊断方法:殊途同归。
Virusdisease. 2020 Jun;31(2):97-105. doi: 10.1007/s13337-020-00599-7. Epub 2020 Jun 13.
4
Test, test, test for COVID-19 antibodies: the importance of sensitivity, specificity and predictive powers.检测 COVID-19 抗体:敏感性、特异性和预测能力的重要性。
Public Health. 2020 Aug;185:88-90. doi: 10.1016/j.puhe.2020.06.006. Epub 2020 Jun 11.
5
The Laboratory Diagnosis of Coronavirus Disease 2019- Frequently Asked Questions.新型冠状病毒肺炎实验室检测FAQ
Clin Infect Dis. 2020 Dec 31;71(11):2996-3001. doi: 10.1093/cid/ciaa742.
6
COVID-19 Testing: The Threat of False-Negative Results.新冠病毒检测:假阴性结果的威胁。
Mayo Clin Proc. 2020 Jun;95(6):1127-1129. doi: 10.1016/j.mayocp.2020.04.004. Epub 2020 Apr 11.
7
Laboratory Diagnosis of COVID-19: Current Issues and Challenges.新型冠状病毒肺炎的实验室诊断:当前的问题和挑战。
J Clin Microbiol. 2020 May 26;58(6). doi: 10.1128/JCM.00512-20.
8
COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation.瑞士的 COVID-19 疫情:关于检测、接触者追踪和隔离的重要性。
Swiss Med Wkly. 2020 Mar 19;150:w20225. doi: 10.4414/smw.2020.20225. eCollection 2020 Mar 9.
9
A new coronavirus associated with human respiratory disease in China.一种在中国与人类呼吸道疾病相关的新型冠状病毒。
Nature. 2020 Mar;579(7798):265-269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3.

新冠病毒疾病病例与新冠病毒检测之间的关系:经合组织国家的面板数据分析

The Relationship Between COVID-19 Cases and COVID-19 Testing: a Panel Data Analysis on OECD Countries.

作者信息

Cirakli Umit, Dogan Ibrahim, Gozlu Mehmet

机构信息

Department of Health Management, Faculty of Economics and Administrative Sciences, Yozgat Bozok University, Yozgat, Turkey.

Department of Economics, Faculty of Economics and Administrative Sciences, Yozgat Bozok University, Yozgat, Turkey.

出版信息

J Knowl Econ. 2022;13(3):1737-1750. doi: 10.1007/s13132-021-00792-z. Epub 2021 Apr 13.

DOI:10.1007/s13132-021-00792-z
PMID:40477406
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8043099/
Abstract

Testing, one of the methods to combat the COVID-19 outbreak, is highly recommended in all countries. Empirical studies on how testing relates to the control of new cases will help highlight the importance of testing in efforts to combat the epidemic. Therefore, this study aims to investigate the relationship between COVID-19 testing and COVID-19 cases. We use panel autoregressive distributed lag analysis to test the effect of COVID-19 test number on the COVID-19 new cases. The data of the study cover the period from March 19, 2020, to May 01, 2020, for 14 OECD countries. Data were obtained from the https://ourworldindata.org/coronavirus website. According to the results, this study shows that increasing the COVID-19 test number will help to reduce new COVID-19 cases. On the other hand, increase in the test number per thousand will probably not contribute to reducing new COVID-19 cases, because countries do not already test by random selection, and even if they do, it will not contribute to detection and isolating of the new cases without identifying risky groups.

摘要

检测作为抗击新冠疫情的方法之一,在所有国家都受到高度推荐。关于检测与新增病例控制之间关系的实证研究,将有助于凸显检测在抗击疫情努力中的重要性。因此,本研究旨在调查新冠病毒检测与新冠病例之间的关系。我们使用面板自回归分布滞后分析来检验新冠病毒检测数量对新冠新增病例的影响。本研究的数据涵盖了2020年3月19日至2020年5月1日期间14个经合组织国家的情况。数据取自https://ourworldindata.org/coronavirus网站。根据结果,本研究表明增加新冠病毒检测数量将有助于减少新冠新增病例。另一方面,每千人检测数量的增加可能无助于减少新冠新增病例,因为各国并非通过随机选择进行检测,而且即便如此,如果不识别风险群体,也无助于发现和隔离新增病例。